Report Type : Therapy Reports
Report Category : Oncology
Report Subcategory : Lymphoma
Lymphoma Global Market Landscape till 2030 :
Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing
Lymphoma:
Lymphoma is a cancer of the lymphatic system, which is part of the body's germ-fighting network.
The main subtypes are:
- Hodgkin's lymphoma (formerly called Hodgkin's disease)
- Non-Hodgkin's lymphoma
Top & Promising Drugs by Company:
- Bristol-Myers Squibb Co- Revlimid (lenalidomide)
- F. Hoffmann-La Roche Ltd- Rituxan (rituximab)
- AbbVie Inc- Imbruvica (ibrutinib)
- AstraZeneca Plc- Calquence (acalabrutinib maleate)
- TG Therapeutics Inc- ublituximab and umbralisib tosylate
- BeiGene Ltd- Brukinsa (zanubrutinib)
- F. Hoffmann-La Roche Ltd- Gazyva (obinutuzumab)
- Takeda Pharmaceutical Co Ltd- Velcade (bortezomib)
- Bristol-Myers Squibb Co- Breyanzi (lisocabtagene maraleucel)
- F. Hoffmann-La Roche Ltd- Polivy (polatuzumab vedotin)
